glp-1 receptor agonist transdermal patch Advances in agonists delivery systems for obesity and diabetes β‘οΈDo GLP1 patches work? π΄I
Description
Binding of GLP-1 has been reported in the nucleus of the solitary tract (NTS) of the medulla oblongata as well
Diabetes 63 (2), 471482
It does mean the science is moving toward a broader view of GLP-1s as metabolic regulators, not just obesity drugs
Final supervision: J.L.G
C.FinkelsteinJ.et al
In February 2024, top-line results from another phase II trial were released 9
